Intech Investment Management LLC Decreases Stock Position in U.S. Physical Therapy, Inc. $USPH

Intech Investment Management LLC lessened its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 18.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 9,763 shares of the company’s stock after selling 2,143 shares during the quarter. Intech Investment Management LLC’s holdings in U.S. Physical Therapy were worth $763,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Assetmark Inc. increased its holdings in shares of U.S. Physical Therapy by 35.7% during the second quarter. Assetmark Inc. now owns 570 shares of the company’s stock valued at $45,000 after acquiring an additional 150 shares in the last quarter. Police & Firemen s Retirement System of New Jersey increased its stake in U.S. Physical Therapy by 5.7% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 3,247 shares of the company’s stock valued at $254,000 after purchasing an additional 176 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of U.S. Physical Therapy by 7.4% in the second quarter. PNC Financial Services Group Inc. now owns 2,949 shares of the company’s stock worth $231,000 after buying an additional 203 shares during the last quarter. Parallel Advisors LLC lifted its stake in shares of U.S. Physical Therapy by 90.6% during the second quarter. Parallel Advisors LLC now owns 448 shares of the company’s stock worth $35,000 after buying an additional 213 shares during the period. Finally, Comerica Bank grew its holdings in shares of U.S. Physical Therapy by 3.0% during the first quarter. Comerica Bank now owns 8,181 shares of the company’s stock valued at $592,000 after buying an additional 237 shares during the last quarter.

Analyst Upgrades and Downgrades

USPH has been the subject of a number of research analyst reports. Zacks Research upgraded U.S. Physical Therapy to a “hold” rating in a research note on Friday, August 8th. Barrington Research reissued an “outperform” rating and issued a $103.00 price objective on shares of U.S. Physical Therapy in a report on Friday, October 24th. Wall Street Zen downgraded U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st. JPMorgan Chase & Co. dropped their target price on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a research report on Monday. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $107.75.

Insider Buying and Selling

In other U.S. Physical Therapy news, Director Nancy Ham sold 600 shares of the company’s stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $81.71, for a total value of $49,026.00. Following the completion of the transaction, the director owned 1,994 shares in the company, valued at approximately $162,929.74. This represents a 23.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Christopher J. Reading sold 2,000 shares of the firm’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $83.53, for a total value of $167,060.00. Following the sale, the chief executive officer owned 114,088 shares in the company, valued at $9,529,770.64. This trade represents a 1.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 3,600 shares of company stock valued at $301,336. Corporate insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Stock Up 0.3%

Shares of USPH opened at $74.37 on Thursday. The company has a market capitalization of $1.13 billion, a price-to-earnings ratio of 32.47, a PEG ratio of 4.41 and a beta of 1.47. U.S. Physical Therapy, Inc. has a 52 week low of $62.77 and a 52 week high of $101.19. The stock’s 50-day moving average price is $82.60 and its 200-day moving average price is $80.10. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Tuesday, August 22nd. The company reported $0.90 earnings per share (EPS) for the quarter. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The company had revenue of $140.66 million during the quarter. On average, sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 12th. Investors of record on Monday, November 17th will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Monday, November 17th. U.S. Physical Therapy’s payout ratio is currently 75.63%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.